SOX11 promotes epithelial/mesenchymal hybrid state and alters tropism of invasive breast cancer cells.


Journal

eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614

Informations de publication

Date de publication:
10 09 2020
Historique:
received: 28 04 2020
accepted: 09 09 2020
pubmed: 11 9 2020
medline: 18 3 2021
entrez: 10 9 2020
Statut: epublish

Résumé

SOX11 is an embryonic mammary epithelial marker that is normally silenced prior to birth. High

Identifiants

pubmed: 32909943
doi: 10.7554/eLife.58374
pii: 58374
pmc: PMC7518891
doi:
pii:

Substances chimiques

Biomarkers, Tumor 0
SOX11 protein, human 0
SOXC Transcription Factors 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Government of the Autonomous Community of the Basque Country, the Department of Industry, Tourism and Trade
ID : KK-2018/00054
Pays : International
Organisme : Wellcome Trust
ID : 203141/Z/16/Z
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Spanish Ministry of Education and Science
ID : SAF2017-84934-R
Pays : International
Organisme : Cancer Research UK
ID : A21855
Pays : United Kingdom

Informations de copyright

© 2020, Oliemuller et al.

Déclaration de conflit d'intérêts

EO, RN, ST, SF, GM, FN, SH, IA, MV, BH No competing interests declared

Références

Nature. 2019 May;569(7757):503-508
pubmed: 31068700
Cell Stem Cell. 2017 Jun 1;20(6):801-816.e7
pubmed: 28285904
PeerJ. 2020 Jan 21;8:e8252
pubmed: 31998552
Int J Mol Sci. 2017 Jan 13;18(1):
pubmed: 28098771
Stem Cell Reports. 2018 Jun 5;10(6):1676-1686
pubmed: 29874626
Nucleic Acids Res. 2013 Apr;41(7):3986-99
pubmed: 23408853
J Pathol. 2017 Oct;243(2):193-207
pubmed: 28707729
Nature. 2019 Aug;572(7769):392-396
pubmed: 31367043
Expert Opin Ther Targets. 2013 Apr;17(4):461-72
pubmed: 23379899
J Cell Biol. 1999 Nov 1;147(3):631-44
pubmed: 10545506
Cancer Discov. 2012 May;2(5):401-4
pubmed: 22588877
Stem Cells. 2011 May;29(5):791-801
pubmed: 21433225
Nature. 2009 Jun 18;459(7249):1005-9
pubmed: 19421193
Sci Signal. 2013 Apr 02;6(269):pl1
pubmed: 23550210
Breast Cancer Res Treat. 2015 Jun;151(2):325-33
pubmed: 25953687
Nat Cell Biol. 2018 Jun;20(6):637-639
pubmed: 29784916
J Mammary Gland Biol Neoplasia. 2019 Sep;24(3):213-230
pubmed: 31069617
Proc Natl Acad Sci U S A. 2011 Mar 1;108(9):3665-70
pubmed: 21307310
Mol Biol Cell. 2005 Sep;16(9):4386-97
pubmed: 15987741
PLoS One. 2013;8(1):e53238
pubmed: 23301048
Oncogene. 2019 Apr;38(17):3151-3169
pubmed: 30622340
Stem Cell Reports. 2013 Dec 27;2(1):78-91
pubmed: 24511467
Cancer Cell Int. 2020 Feb 28;20:63
pubmed: 32140076
Breast Cancer Res. 2013 Mar 18;15(2):R25
pubmed: 23506684
Breast Cancer Res. 2011 Aug 11;13(4):R79
pubmed: 21834968
Nat Cell Biol. 2018 Jun;20(6):666-676
pubmed: 29784918
Mol Med Rep. 2012 Sep;6(3):575-80
pubmed: 22692246
J Cell Biol. 1987 Jul;105(1):117-25
pubmed: 3301863
Commun Biol. 2018 Dec 13;1:228
pubmed: 30564749
Dev Biol. 2017 Oct 15;430(2):266-274
pubmed: 28774727
Genome Biol. 2018 Mar 14;19(1):31
pubmed: 29540203
Pediatr Dev Pathol. 2003 Sep-Oct;6(5):398-413
pubmed: 14708733
J Pathol. 2016 Nov;240(3):315-328
pubmed: 27512948
J Pathol. 2015 Nov;237(3):363-78
pubmed: 26172396
Oncotarget. 2016 Mar 15;7(11):13106-21
pubmed: 26894864
Sci Rep. 2016 Jun 24;6:28623
pubmed: 27340107
Cancers (Basel). 2020 Jan 30;12(2):
pubmed: 32019099
J Natl Cancer Inst. 2019 Apr 1;111(4):388-398
pubmed: 29961873
Front Mol Neurosci. 2018 Jun 19;11:211
pubmed: 29973868
Cancer Res. 2017 Sep 15;77(18):4858-4867
pubmed: 28674079
J Cell Biol. 1987 Jul;105(1):105-15
pubmed: 3038923
Genes Dev. 2006 Dec 1;20(23):3199-214
pubmed: 17158740
Cell. 2016 Jun 30;166(1):21-45
pubmed: 27368099
Nat Commun. 2019 Sep 6;10(1):4042
pubmed: 31492871
Semin Cancer Biol. 2020 Jun 20;:
pubmed: 32574812
Nat Rev Mol Cell Biol. 2013 Jun;14(6):329-40
pubmed: 23698583
NPJ Breast Cancer. 2017 Apr 19;3:14
pubmed: 28649654
Nat Cell Biol. 2018 Jun;20(6):677-687
pubmed: 29784917
Sci Rep. 2015 Dec 14;5:18133
pubmed: 26656559
Nature. 2012 Apr 18;486(7403):346-52
pubmed: 22522925
Breast Cancer Res. 2012 Dec 06;14(6):R154
pubmed: 23216791
PLoS One. 2011;6(9):e25354
pubmed: 21980432
Haematologica. 2009 Nov;94(11):1555-62
pubmed: 19880778

Auteurs

Erik Oliemuller (E)

The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom.

Richard Newman (R)

The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom.

Siu Man Tsang (SM)

The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom.

Shane Foo (S)

Translational Immunotherapy Team, Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom.

Gareth Muirhead (G)

The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom.

Farzana Noor (F)

The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom.

Syed Haider (S)

The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom.

Iskander Aurrekoetxea-Rodríguez (I)

CIC bioGUNE, Basque Research and Technology Alliance (BRTA), Derio, Spain.

Maria dM Vivanco (MD)

CIC bioGUNE, Basque Research and Technology Alliance (BRTA), Derio, Spain.

Beatrice A Howard (BA)

The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH